MUSSINI, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 55.607
EU - Europa 28.807
AS - Asia 24.309
SA - Sud America 4.215
AF - Africa 592
OC - Oceania 105
Continente sconosciuto - Info sul continente non disponibili 33
AN - Antartide 1
Totale 113.669
Nazione #
US - Stati Uniti d'America 54.715
GB - Regno Unito 9.256
SG - Singapore 8.145
IT - Italia 7.499
CN - Cina 7.079
HK - Hong Kong 3.844
BR - Brasile 3.368
DE - Germania 2.471
SE - Svezia 2.427
VN - Vietnam 1.576
FI - Finlandia 1.447
RU - Federazione Russa 1.378
FR - Francia 830
UA - Ucraina 746
ID - Indonesia 672
TR - Turchia 614
KR - Corea 562
CA - Canada 529
NL - Olanda 511
BG - Bulgaria 493
IN - India 444
AR - Argentina 357
ES - Italia 244
MX - Messico 235
ZA - Sudafrica 234
BD - Bangladesh 201
JP - Giappone 187
AT - Austria 181
LT - Lituania 175
PL - Polonia 171
IR - Iran 168
IE - Irlanda 162
BE - Belgio 144
EC - Ecuador 143
SI - Slovenia 135
IQ - Iraq 124
CH - Svizzera 103
MY - Malesia 95
CO - Colombia 93
AU - Australia 91
RO - Romania 86
PK - Pakistan 85
CZ - Repubblica Ceca 76
MA - Marocco 73
CL - Cile 67
AE - Emirati Arabi Uniti 57
PY - Paraguay 57
IL - Israele 43
PE - Perù 43
SA - Arabia Saudita 43
VE - Venezuela 43
UZ - Uzbekistan 42
EG - Egitto 41
JO - Giordania 41
TH - Thailandia 38
KE - Kenya 35
PH - Filippine 34
GR - Grecia 33
NO - Norvegia 32
RS - Serbia 30
AZ - Azerbaigian 29
EE - Estonia 29
DO - Repubblica Dominicana 26
UY - Uruguay 25
EU - Europa 24
NP - Nepal 24
TN - Tunisia 24
UG - Uganda 24
ET - Etiopia 23
KZ - Kazakistan 23
TW - Taiwan 23
BZ - Belize 21
DZ - Algeria 21
AL - Albania 20
PA - Panama 18
KG - Kirghizistan 17
MK - Macedonia 16
DK - Danimarca 15
PT - Portogallo 15
NZ - Nuova Zelanda 14
OM - Oman 14
SN - Senegal 14
BO - Bolivia 13
SK - Slovacchia (Repubblica Slovacca) 13
CR - Costa Rica 11
JM - Giamaica 11
LV - Lettonia 11
BA - Bosnia-Erzegovina 10
NG - Nigeria 10
TZ - Tanzania 10
GE - Georgia 9
HR - Croazia 9
HU - Ungheria 9
KW - Kuwait 9
LB - Libano 9
GA - Gabon 8
LK - Sri Lanka 8
MD - Moldavia 8
A2 - ???statistics.table.value.countryCode.A2??? 7
BY - Bielorussia 7
Totale 113.479
Città #
Southend 6.586
Fairfield 6.140
Santa Clara 5.744
Singapore 5.510
Ashburn 5.392
Hong Kong 3.790
Woodbridge 3.406
Chandler 3.320
Houston 2.679
Seattle 2.408
Hefei 2.336
Wilmington 2.089
Cambridge 2.065
London 1.638
Nyköping 1.527
Ann Arbor 1.338
Jacksonville 1.299
Dearborn 1.228
Beijing 1.159
Helsinki 1.046
Los Angeles 998
Chicago 936
Modena 928
New York 800
San Diego 741
Dallas 575
Jakarta 566
Princeton 547
Munich 537
Ho Chi Minh City 528
Milan 526
Seoul 525
Rome 500
Sofia 483
Moscow 414
The Dalles 410
Shanghai 391
Salt Lake City 351
Bologna 344
Buffalo 343
Izmir 327
São Paulo 319
Hanoi 299
Eugene 276
Bremen 260
Council Bluffs 243
Frankfurt am Main 215
Redwood City 186
San Jose 184
Nuremberg 179
Tampa 175
Boardman 159
Toronto 156
Turku 145
Amsterdam 144
Tokyo 144
Dublin 143
Redondo Beach 143
Fremont 141
Elk Grove Village 136
Naples 135
Brussels 132
Warsaw 132
Phoenix 129
Montreal 126
Atlanta 124
Des Moines 121
Brooklyn 114
Rio de Janeiro 111
Johannesburg 109
Columbus 108
Kent 106
Parma 106
Florence 103
Mexico City 99
Orem 99
Guangzhou 98
Falls Church 96
Lauterbourg 95
Falkenstein 92
Chennai 89
Denver 89
Dong Ket 89
Stockholm 89
Norwalk 83
Paris 82
Vienna 82
Sterling 78
Turin 73
Boston 71
Haiphong 71
Nanjing 71
San Francisco 71
Lappeenranta 70
Palermo 70
Bari 69
Ottawa 67
Poplar 66
Reggio Emilia 66
Detroit 65
Totale 79.863
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.586
Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: An Italian cost impact study 785
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 743
Comparative evaluation of subtyping tools for surveillance of newly emerging HIV-1 strains 677
Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease 603
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 574
Migration and health: A retrospective study about the prevalence of HBV, HIV, HCV, tuberculosis and syphilis infections amongst newly arrived migrants screened at the Infectious Diseases Unit of Modena, Italy 568
Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach 565
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 467
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 461
Acinetobacter baumannii Resistance to Sulbactam/Durlobactam: A Systematic Review 444
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity 411
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 406
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 402
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 400
Efficient T cell compartment in HIV+ patients receiving orthotopic liver transplant and immunosuppressive therapy 395
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. 386
Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study 379
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 365
Analysis of inflammasomes and antiviral sensing components reveals decreased expression of NLRX1 in HIV-positive patients assuming efficient antiretroviral therapy 365
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 364
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 364
A frailty index predicts post-liver transplant morbidity and mortality in HIV-positive patients 360
Increased plasma levels of extracellular mitochondrial DNA during HIV infection: a new role for mitochondrial damage-associated molecular patterns during inflammation. 359
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 357
Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV 350
NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption. 349
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 347
T cell homeostasis in centenarians: from the thymus to the periphery. 341
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 340
Successful treatment of HIV-1 infection increases the expression of a novel, short transcript for IL-18 receptor α chain 339
MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients 338
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 338
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 335
Gastric Mucormycosis in a Liver and Kidney Transplant Recipient: Case Report and Concise Review of Literature 332
Inverse correlation between vascular calcification and bone mineral density in human immunodeficiency virus-infected patients 330
Ageing and inflammation in patients with HIV infection 327
Exploring viral reservoir: The combining approach of cell sorting and droplet digital PCR 324
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 318
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles 317
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 315
Absence of liver steatosis in HIV-HCV co-infected patients receiving regimens containing tenofovir or abacavir 312
HIV-1 Infection and the Aging of the Immune System: Facts, Similarities and Perspectives 312
Voice assistance to develop a participatory research and action to improve health trajectories of people with PACS 311
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 311
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 310
Th1 and Th17 pro-inflammatory profile characterizes iNKT cells in virologically suppressed HIV+ patients with low CD4/CD8 ratio 308
Impact of polypharmacy on antiretroviral prescription in people living with HIV. 308
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 307
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 307
Decay pattern of anti–SARS–CoV–2 antibodies in PWH 306
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 303
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 303
Machine learning algorithm to predict weight change in ART experienced PWH 301
Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. 295
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 293
Cytometry, immunology, and HIV infection: Three decades of strong interactions. 291
Re: Lebentrau S, Gilfrich C, Vetterlein MW, Schumacher H, Spachmann PJ, Brookman-May SD, Fritsche HM, Schostak M, Wagenlehner F, Burger M, May M, MR2 study group (2017) Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship. Int Urol Nephrol 49:1311–1318 291
Apoptotic features of peripheral blood granulocytes and monocytes during primary, acute HIV infection. 289
Mucorales-specific T cells in patients with hematologic malignancies 287
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 287
Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients 286
Correlates of frailty phenotype and frailty index and their associations with clinical outcomes 286
Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. 285
HIV-DNA content in different CD4+ T-cell subsets correlates with CD4+ cell : CD8+ cell ratio or length of efficient treatment 285
Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe. 285
Altered Expression of PYCARD, Interleukin 1β, Interleukin 18, and NAIP in Successfully Treated HIV-Positive Patients With a Low Ratio of CD4+ to CD8+ T Cells 285
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 285
Predictive Value of Intracellular HIV-1 DNA Levels During CD4-Guided Treatment Interruption in HIV(+) Patients 283
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women 283
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 283
CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption. 283
Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study 282
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 282
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 282
Novel genetic association of TNF-α-238 and PDCD1-7209 polymorphisms with long-term non-progressive HIV-1 infection. 281
Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy. 281
Cytotoxic granule release dominates gag-specific CD4+ T-cell response in different phases of HIV infection. 280
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 280
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 279
Lower Frailty Is Associated with Successful Cognitive Aging Among Older Adults with HIV 279
Changes in central adipose tissue after switching to integrase inhibitors 279
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia 278
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 278
Hypokalemia in Patients with COVID-19 272
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 272
Non–alcoholic to metabolic associated fatty liver disease: cardiovascular implications of a change in terminology in patients living with HIV 270
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients 270
Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease 270
The protease inhibitor atazanavir triggers autophagy and mitophagy in human preadipocytes 269
Impact of Pre-Analytical Time on the Recovery of Pathogens from Blood Cultures: Results from a Large Retrospective Survey 267
Different sensitivity to apoptosis in cells of monocytic or lymphocytic origin chronically infected with human immunodeficiency virus type-1 266
Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis. 266
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 266
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 264
Circulating Mitochondrial DNA and Lipopolysaccharide-Binding Protein but Not Bacterial DNA Are Increased in Acute Human Immunodeficiency Virus Infection. 264
Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital 263
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 262
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 262
Incidence of HCV infection amongst HIV positive men who had sex with men and prevalence data from patients followed at the Infectious Diseases Clinic of Modena, Italy 261
Totale 34.912
Categoria #
all - tutte 511.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 511.281


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.072 0 0 0 0 0 0 1.340 1.557 865 1.343 1.171 796
2021/202210.634 777 1.030 792 554 405 713 642 588 1.211 850 1.800 1.272
2022/202310.959 1.236 1.234 906 965 1.235 1.341 331 1.062 1.203 222 573 651
2023/20248.748 363 588 619 844 1.450 790 703 1.129 330 282 531 1.119
2024/202524.714 804 410 453 1.816 4.071 3.767 1.679 1.555 2.970 1.747 2.407 3.035
2025/202626.084 3.210 2.040 4.312 6.024 6.922 3.361 215 0 0 0 0 0
Totale 114.703